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Abstract
Cluster-level dynamic treatment regimens can be used to guide sequential, intervention or
treatment decision-making at the cluster level in order to improve outcomes at the individual
or patient-level. In a cluster-level DTR, the intervention or treatment is potentially adapted
and re-adapted over time based on changes in the cluster that could be impacted by prior
intervention, including based on aggregate measures of the individuals or patients that comprise
it. Cluster-randomized sequential multiple assignment randomized trials (SMARTs) can be used
to answer multiple open questions preventing scientists from developing high-quality cluster-
level DTRs. In a cluster-randomized SMART, sequential randomizations occur at the cluster level
and outcomes are at the individual level. This manuscript makes two contributions to the design
and analysis of cluster-randomized SMARTs: First, a weighted least squares regression approach
is proposed for comparing the mean of a patient-level outcome between the cluster-level DTRs
embedded in a SMART. The regression approach facilitates the use of baseline covariates which
is often critical in the analysis of cluster-level trials. Second, sample size calculators are derived
for two common cluster-randomized SMART designs for use when the primary aim is a between-
DTR comparison of the mean of a continuous patient-level outcome. The methods are motivated
by the Adaptive Implementation of Effective Programs Trial, which is, to our knowledge, the
first-ever cluster-randomized SMART in psychiatry.
Keywords: adaptive interventions, adaptive treatment strategies, dynamic treatment regimens,
group-randomized, cluster-randomized, ADEPT
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Introduction
Interventions aimed at improving individual-level outcomes often occur at a cluster-
level (Raudenbush and Bryk 2002; Donner and Klar 2010; Murray 1998). Often, it
may be necessary to use a tailored, dynamic approach to intervention in order to address
cluster-level heterogeneity in the kind of intervention necessary to improve individual-
level outcomes (Kilbourne et al. 2013).
Cluster-level dynamic treatment regimens (DTRs), also known as adaptive
interventions, can be used to guide such sequential intervention decision-making at the
cluster level. In a cluster-level DTR, the cluster-level intervention is potentially adapted
(or re-adapted) over time based on changes in the cluster that could be impacted
by prior intervention (e.g. adapting based on aggregate measures of the individuals
that comprise it). A cluster-level DTR may also include intervention components
dynamically tailored to the individuals within clusters.
Sequential multiple assignment randomized trials (SMART) represent an important
data collection tool for informing how best to construct DTRs (Kosorok and Moodie
2015; Lavori and Dawson 2014; Chakraborty and Moodie 2013; Lei et al. 2012;
Murphy 2005). The focus of most SMARTs to date has been the development of
individual-level DTRs to improve individual-level outcomes (e.g., see Methodology
Center (2016)).
There has been much less focus on analytic or design issues related to cluster-
randomized SMARTs for developing cluster-level DTRs. In a cluster-randomized
SMART, randomizations occur at the cluster level, yet outcomes are at the level
of individuals within the cluster. Using the Adaptive Implementation of Effective
Programs Trial (ADEPT; Kilbourne et al. (2014)) as a motivating example, the focus
of this paper is on primary aim analysis and sample size considerations in cluster-
randomized SMARTs. ADEPT, which is currently in the field, is to our knowledge the
first-ever cluster-randomized SMART. The overarching goal of ADEPT is to develop
a cluster-level DTR to improve the adoption of an evidence-based practice (EBP) for
mood disorders in community-based mental health clinics and thereby improve patient-
level mental health outcomes.
This manuscript makes two contributions to the design and analysis of cluster-
randomized SMARTs. First, we develop a regression approach for comparing the
mean of a continuous patient-level outcome between the cluster-level DTRs embedded
in a SMART. The regression approach is an extension of the estimator in Nahum-
Shani et al. (2012) first introduced by Orellana et al. (2010). The regression approach
facilitates the use of individual- and cluster-level baseline (pre-randomization)
covariates in the analysis of data from a cluster-randomized SMART.
Second, we develop sample size formulae (for the total number of clusters) to be
used when the primary aim of the cluster-randomized SMART is a comparison of
the mean of a continuous patient-level outcome between two DTRs beginning with
different treatments. This is a common primary aim in SMARTs; see Oetting et al.
(2011, continuous end of study outcome) and Li and Murphy (2011, survival outcome).
The regression approach can be used with any cluster-randomized SMART with
repeated cluster-level randomizations. Sample size formulae are developed for two
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common types of two-stage SMART designs: the one used in ADEPT, and for a more
common type of SMART.
Consistent with the proposed regression approach, which facilitates the use of
baseline covariates, the sample size formulae allow scientists to incorporate the
correlation between a pre-specified baseline cluster-level covariate and patient-level
outcomes, which leads to a reduction in the minimum number of clusters necessary
(Spybrook et al. 2011). This manuscript extends the work of Ghosh et al. (2015), which
develops sample size calculators for a single type of cluster-randomized SMART in a
non-regression context, i.e., without covariates.
Sequential, Multiple Assignment Randomized Trials with
Cluster-level Randomization
Sequential multiple assignment randomized trials (SMARTs) are multi-stage
randomized trial designs used explicitly for the purpose of building high-quality
dynamic treatment regimens (Lavori and Dawson 2000; Murphy 2005). The multiple
stages at which randomizations occur correspond to critical intervention decision
points. At each decision point, randomization is used to address a question concerning
the dosage (duration, frequency or amount), intensity, type, or delivery of treatment.
Here we consider SMARTs for developing cluster-level DTRs where the unit of
randomization (and re-randomization) is a cluster and the outcomes are measured at
the level of the individual.
Motivating Example: The ADEPT SMART Study
These methods are motivated by the Adaptive Implementation of Effective Programs
Trial (ADEPT; Kilbourne et al. (2014) and see Figure 1), a cluster-randomized SMART
in psychiatry. The overall aim of ADEPT is to develop a cluster-level DTR to improve
the adoption of an EBP for mood disorders in community-based mental health clinics
across the US states of Colorado and Michigan. The patient-level EBP is known as
Life Goals (Kilbourne et al. 2012), a collaborative care, psychosocial intervention for
mood disorders delivered to patients in six individual or group sessions. The primary
outcome in ADEPT is a continuous, patient-level measure of mental health quality of
life (MH-QOL).
ADEPT includes several interventions: the replicating effectiveness program (REP),
REP plus External Facilitation (REP+EF), and REP plus External and Internal
Facilitation (REP+EF+IF). REP is a cluster-level intervention focused on standardizing
the implementation of the EBP into routine care through toolkit development, provider
training, and program assistance. Facilitation is a cluster-level coaching intervention to
help support the use of EBPs. External Facilitation is by phone and focuses on technical
aspects of how to adopt the EBP; Internal Facilitation is in-person and involves working
with a clinic manager to further embed the EBP.
ADEPT, which is currently in the field, involves community-based mental health
clinics (approximately N = 60) that have failed to respond to an initial 6 months of
REP (pre-randomization). During these 6 months, each clinic i = 1, . . . , N is expected
to identify approximately mi = 10 to 25 patients with mood disorders, all of which are
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Figure 1. Schematic of ADEPT. The encircled R signifies randomization; cluster-level
randomizations occurred at baseline and after 6 months of REP+EF or REP+EF+IF
following identification of clinic responder status.
followed for patient-level outcomes throughout the study. Clinics that enter the study
(i.e. did not respond to REP at month 6) are randomized with equal probability to
receive additional REP+EF or REP+EF+IF. After another 6 months, (i) REP + EF sites
that are still non-responsive are randomized with equal probability to either continue
REP + EF or augment with IF (REP + EF + IF) for an additional 12 months, and
(ii) facilitation interventions are discontinued for sites that are responsive. A clinic is
identified as “not responding” at months 6 and 12 if < 50% of the patients identified to
be part of Life Goals during months 0-6 have received ≥3 Life Goals sessions.
Table 1. The three DTRs embedded in ADEPT (Figure 1)
DTR Label Second-stage Status at end Third-stage Cell in Known
(a1, a2) Treatment of second-stage Treatment A1 R A2 Figure IPW
(1, 1) REP+EF Resp REP 1 1 A 2Non Resp REP+EF 1 0 1 B 4
(1,−1) REP+EF Resp REP 1 1 A 2Non Resp REP+EF+IF 1 0 -1 C 4
(−1, .) REP+EF+IF Resp REP -1 1 D 2Non Resp REP+EF+IF -1 0 E 2
By design, ADEPT has three DTRs embedded within it (see Table 1); each DTR
is labeled (a1, a2). DTR (1,−1), for example, offers REP+EF at month 6; then,
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for clinics that remain non-responsive at month 12, REP+EF is augmented with IF;
whereas, EF is discontinued for clinics who are responsive at month 12.
The Prototypical SMART Design
In ADEPT, only clinics not responding to REP+EF were re-randomized at the next
stage. This type of SMART (but with individual-level randomizations) has been
previously employed in autism research, see Kasari et al. (2014) and Almirall et al.
(2016).
Many other types of SMART designs are possible (see Methodology Center
(2016) for a comprehensive list with individual-level randomizations), including
SMARTs where all units are subsequently re-randomized to the same set of next-
stage intervention options (e.g., Chronis-Tuscano et al. (2016)) and others where all
units are re-randomized, but to different next-stage interventions options depending on
response/non-response to first-stage intervention (e.g., Lu et al. (2015)). Ultimately, the
decision to choose a particular type of SMART is driven by scientific considerations.
By far the most common type of SMART is a two-stage design where (i) all units
are randomized to two first-stage treatment options, (ii) a subset of units at the end of
stage 1 (e.g., non-responders) are re-randomized to second-stage intervention options
(regardless of choice of first-stage intervention), and (iii) the remaining subset of units
(e.g., responders) are not re-randomized. See Figure 2 for a generic example. We call
this a “prototypical SMART design” given its popularity. Note that in the case of the
prototypical SMART, there are four embedded DTRs; see Table 2.
Figure 2. Schematic of a prototypical SMART design
Published examples of the prototypical SMART (with individual-level randomiza-
tions) include Pelham et al. (2016) in attention-deficit/hyperactivity disorder, Gunlicks-
Stoessel et al. (2015) in adolescent depression, August et al. (2014) in conduct disorder
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Table 2. The four DTRs embedded in a prototypical SMART (Figure 2)
DTR Label First-stage Status at end Second-stage Cell in Known
(a1, a2) Treatment of first-stage Treatment A1 R A2 Figure IPW
(1, 1) T11
Resp T21 1 1 A 2
Non Resp T22 1 0 1 B 4
(1,−1) T11 Resp T21 1 1 A 2Non Resp T23 1 0 -1 C 4
(−1, 1) T12 Resp T24 -1 1 D 2Non Resp T25 -1 0 1 E 4
(−1,−1) T12 Resp T24 -1 1 D 2Non Resp T26 -1 0 -1 F 4
prevention, Sherwood et al. (2016) and Naar-King et al. (2015) in weight loss, and
McKay et al. (2015) in cocaine/alcohol use.
Common Primary Aims in a SMART
This manuscript develops methods for comparing the mean of a continuous individual-
level outcome between the DTRs embedded in a cluster-randomized SMART. This
comparison can be conceptualized in various ways as a primary aim (Oetting et al.
2011; Almirall et al. 2014): (i) To compare first stage intervention options (averaging
over the second stage intervention). In ADEPT, this is a comparison of DTR (-1,.) vs
the DTRs {(1,1), (1,-1)} (this was the primary aim in ADEPT; see Kilbourne et al.
(2014)). (ii) To compare second stage intervention options (averaging over the first
stage intervention). In the prototypical design, if the second stage treatments are the
same for both first stage treatments, this would be a comparison of DTRs {(1,1), (-
1,1)} vs DTRs {(1,-1), (-1,-1)} (e.g. see aim 3 in Pelham et al. (2016)). (iii) To compare
the mean outcome between two DTRs beginning with the same first-stage treatment.
In ADEPT, this is a comparison of DTR (1,1) vs (1, -1). (iv) To compare the mean
outcome between two DTRs that begin with different first stage treatments. In ADEPT,
this is a comparison of (1,1) vs (-1,.) or of (1,-1) vs (-1,.).
The next section develops a regression estimator that can be used to address all of
these primary aims using data from a cluster-randomized SMART. Following that, we
derive sample size formulae for aim (iv). Simple extensions of standard sample size
formulae may be used for primary aims (i), (ii), and (iii).
Methodology
Marginal Mean Model
For each SMART participant j = 1, . . . ,mi within each site i = 1, . . . , N we envision
a primary end-of-study individual-level outcome Yij . Let the p× 1 vector Xij denote
a pre-specified set of baseline covariates measured prior to the initial randomization.
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Xij may include both patient-level covariates (e.g. age) or cluster-level covariates (e.g.
clinic location).
Denote Ea1,a2(Yij |Xij) as the marginal mean of Yij had the entire population
been assigned to the DTR (a1, a2), conditional on baseline covariates, Xij (Rubin
1978; Neyman et al. 1935). Ea1,a2(Yij |Xij) is marginal in that it averages over the
response/non-response measure used in the DTR (a1, a2).
Let µ(Xij , a1, a2;β, η) denote a marginal structural model (Orellana et al. 2010;
Murphy et al. 2001; Robins et al. 2000; Herna´n et al. 2000; Robins 1999) for the
mean Ea1,a2(Yij |Xij) which is linear in the unknown parameters (β, η). We provide
examples below. β is a q × 1 vector used to denote the causal effects between the DTRs,
and η is the p× 1 vector used to denote the associational effects between Xij and Yij .
Example 1: ADEPT. An example marginal mean model for the ADEPT study is
µ(Xij , a1, a2;β, η) = β0 + β1a1 + β2a2Ia1=1 + η
TXij (1)
Here we use a β with q = 3 to capture the causal effects for the 3 embedded DTRs.
Xij could include, for example, the three baseline site-level variables used to stratify
the initial randomization: US state (Colorado vs Michigan), whether the site was a
primary care or mental health site, and a site-average of individual MH-QOL scores.
Using this model to address a primary aim of type (iv) above, the difference in the
mean outcome had all clusters received DTR (1,1) vs had all clusters received DTR
(-1,.)—i.e., E1,1(Yij)− E-1,.(Yij)—is given by 2β1 + β2.
Example 2: Prototypical SMART. In the prototypical SMART, we use a β with q = 4
to capture the causal effects for the 4 embedded DTRs.
µ(Xij , a1, a2;β, η) = β0 + β1a1 + β2a2 + β3a1a2 + η
TXij (2)
Here, the comparison of mean outcomes had all clusters received DTR (1,1) vs had all
clusters received DTR (-1,-1)—i.e. E1,1(Yij)− E-1,-1(Yij)—is given by 2(β1 + β2).
Estimation
We now present an estimator for the unknown (β, η).
Notation. Let Xi denote the mi × p matrix (Xi1, Xi2, . . . , Ximi)T of
covariates and let µ(Xi, a1, a2;β, η) be the mi × 1 vector of means
(µ(Xi1, a1, a2;β, η), . . . , µ(Ximi , a1, a2;β, η))
T . Let Yi be the mi × 1 vector of
responses (Yi1, Yi2, . . . , Yimi)
T . LetA1i denote the observed (i.e., randomly assigned)
stage 1 treatment. In ADEPT, A1i = 1 implies that cluster i received REP+EF as
an initial treatment while A1i = −1 implies cluster i received REP+EF+IF. Let Ri,
a binary variable, denote responder/non-responder status at the end of stage 1. In
ADEPT, Ri = 1 if cluster i is a responder at the end of the first stage and Ri = 0 if
cluster i is a non-responder. Let A2i denote the observed (i.e., randomly assigned)
stage 2 treatment. Note that, depending on the SMART design, A2i may not be defined
for some clusters i depending on the value of (A1i, Ri). In ADEPT, A2i is defined
only for clusters with A1i = 1 and Ri = 0. In the prototypical SMART, A2i is not
defined for clusters with Ri = 1. See Tables 1 and 2.
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Estimator. Building on Orellana et al. (2010), Nahum-Shani et al. (2012) and Lu et al.
(2015), we obtain βˆ, ηˆ by solving for β, η in the following estimating equations:
0 =
N∑
i=1
Ui(A1i, Ri, A2i,Xi,Yi;β, η) ,
N∑
i=1
∑
(a1,a2)
I(A1i, Ri, A2i, a1, a2)
·WiD(Xi, a1, a2)TV (a1, a2,mi)-1(Yi − µ(Xi, a1, a2;β, η)). (3)
D(Xi, a1, a2) is the mi × (q + p) derivative of µ(Xi, a1, a2;β, η) with respect
to (β, η); it can be thought of as the “design matrix” for DTR (a1, a2). For
example, using the model in Equation 1 for ADEPT, the jth row of D(Xi, a1, a2) is
(1, a1, a2Ia1=1, Xij).
V (a1, a2,mi) is a working model for Cova1,a2(Yi|Xi), the mi ×mi covariance
matrix for Yi conditional on Xi for DTR (a1, a2). In practice, V (a1, a2,mi) is
unknown and must be estimated prior to solving Equation 3; see Implementation
section. Note that V (a1, a2,mi) depends on mi through its size, not its structure.
I(A1i, Ri, A2i, a1, a2) (abbreviated Ii(a1,a2)) is a cluster-level indicator function
which identifies whether (equals 1) or not (equals 0) cluster i was assigned to a
sequence of treatments that is consistent with DTR (a1, a2). For example, in ADEPT,
if A1i = 1, Ri = 0, and A2i = -1, then cluster i is consistent only with DTR (1,-1);
whereas ifA1i = 1, Ri = 1, then cluster i is consistent with both DTR (1,1) and (1,-1).
Wi are the known cluster-level inverse probability weights (IPW, Orellana et al.
(2010)), Wi = 1/[Pr(A1i)Pr(A2i|A1i, Ri)]. See Tables 1 and 2 for the known values
of Wi in ADEPT and the prototypical SMART.
Following Orellana et al. (2010), the estimators (βˆ, ηˆ), derived from solving
Equation 3 are consistent and asymptotically normally distributed if the mean model
(e.g., Equation 1 for ADEPT) is correctly specified. As in the generalized estimating
equations literature (Liang and Zeger 1993, 1986), there is no requirement that
V (a1, a2,mi) be a correct model for Cova1,a2(Yi|Xi). See supplementary material
for a sketch of the derivations.
Intuition for the Weights. By design, in the observed data in a SMART, different
clusters have different probabilities of being consistent with a specific DTR. For
example, clusters assigned to cells A and B are consistent with DTR (1,1) (see Figure 1
and Table 1). However, clusters assigned to cell A had a 50% chance of being consistent
with DTR (1,1), whereas clusters assigned to cell B had 25% chance of being consistent
with DTR (1,1). Ignoring this known imbalance—i.e., using an unweighted average of
observations in cells A and B to estimate the mean outcome had the entire population of
clusters been assigned to DTR (1,1)—would cause the Cell A observations to have an
unfairly larger influence on your estimate, leading to bias. The weights are designed to
counteract this known imbalance and ensure all clusters consistent with DTR (a1, a2)
are represented equally. For example, in ADEPT, clusters in cell A are weighted by 2,
whereas clusters in cell B are weighted by 4.
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Implementation
Typically, in clustered settings, our working model for Cova1,a2(Yi|Xi),
V (a1, a2,mi), is taken to be “exchangeable” and independent of Xi, i.e.,
V (a1, a2,mi) = σ
2∗
a1,a2 · Exchmi(ρ∗a1,a2). Here σ2∗a1,a2 and ρ∗a1,a2 are scalars
representing the conditional (on Xi) variance and intra-cluster correlation (ICC) of
the outcome under DTR (a1, a2), and Exchmi(ρ
∗
a1,a2 ) is an mixmi exchangeable
matrix (i.e. [Exch(ρ)]ii = 1 and [Exch(ρ)]ij = ρ for i 6= j). The estimators (βˆ, ηˆ)
are obtained using the following steps:
Step 1: Solve Equation 3 with V (a1, a2,mi) set to the identity matrix to obtain
(βˆ0, ηˆ0). For each embedded DTR (a1, a2) obtain the residuals ˆij,(a1,a2)(βˆ0, ηˆ0) =
Yij − µˆ(Xij , a1, a2; βˆ0, ηˆ0).
Step 2: Estimate σ2∗a1,a2 and ρ
∗
a1,a2 using:
σˆ2∗a1,a2 =
N∑
i=1
[WiIi(a1,a2)
mi∑
j=1
ˆ2ij,(a1,a2)
]
N∑
i=1
WiIi(a1,a2)mi
and ρˆ∗a1,a2 =
N∑
i=1
[WiIi(a1,a2)
mi∑
j=1
mi∑
k 6=j
ˆij,(a1,a2) ˆik,(a1,a2)]
σˆ2∗a1,a2
N∑
i=1
WiIi(a1,a2)mi(mi−1)
.
(4)
Step 3: Solve Equation 3 with V (a1, a2,mi) set to Vˆ (a1, a2,mi) = σˆ2∗a1,a2 ·
Exchmi(ρˆ
∗
a1,a2) to obtain (βˆ1, ηˆ1).
Step 4: Repeat Steps 2 and 3 with ˆij,(a1,a2)(βˆ1, ηˆ1) to obtain final estimates (βˆ, ηˆ).
In simulations we do not find appreciable performance gains by iterating Steps 2
and 3 more than twice. Equations 4 can be seen as extensions of standard working
correlation estimators used in GEE literature (Liang and Zeger 1993, 1986).
Some analysts may choose to specify a working correlation structure which is equal
for all DTR’s. In this case, one could take a simple average of the estimates in Equation
4 across all regimens (a1, a2).
Lastly, it is well known that by replacing the known Wi in each step above with
estimated weights, statistical efficiency of the estimators may be improved (Robins
et al. 1995; Hernan et al. 2002; Hirano et al. 2003; Brumback 2009; Williamson et al.
2014; Bembom and van der Laan 2007)
Standard Error Estimation
To estimate the variance of (βˆ, ηˆ) we use the plug-in estimator, given by the (q + p)×
(q + p) matrix 1/N · Σˆβˆ,ηˆ = 1/N · Jˆ -1AˆJˆ -1 where
Jˆ = 1N
N∑
i=1
∑
(a1,a2)
I(A1i, Ri, A2i, a1, a2)WiD(Xi, a1, a2)T Vˆ (a1, a2,mi)-1D(Xi, a1, a2)
Aˆ = 1N
N∑
i=1
Ui(A1i, Ri, A2i,Xi,Yi; βˆ, ηˆ)UTi (A1i, Ri, A2i,Xi,Yi; βˆ, ηˆ).
See supplementary materials for an adjustment to the standard errors for the case when
weights are estimated.
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Hypothesis Testing
For any linear combination of (β, η), say cT (β, η) where c is a (q + p)-dimensional
column vector, we use the univariate Wald statistic Z =
√
NcT (βˆ, ηˆ)/
√
cT Σˆβˆ,ηˆc
to test the null hypothesis H0 : cT (β, η) = 0. For example, in ADEPT, to test the
difference in means had the entire population of clusters followed DTR (1,1) versus
DTR (-1,.) (i.e. primary aim (iv) above) using the model in Equation 1, we set
c = (0, 2, 1, 0p)
T . In large samples Z has a standard normal distribution under the null
hypothesis. Hence, an α level test is “reject H0 when |Z| > zα/2,” where zα/2 is the
upper α/2 quantile of a standard normal distribution.
Sample Size Formulae
For both ADEPT and the prototypical SMART, we develop sample size formulae
for the total number of clusters N for comparing the mean patient-level outcome
between two embedded DTRs beginning with different stage 1 treatments. Specifically,
for ADEPT, formulae are developed for testing null hypotheses of the form H0 :
E1,b2(Yij)− E-1,.(Yij) = 0 for a fixed b2 ∈ (−1, 1) against alternate hypotheses of the
form H1 : E1,b2(Yij)− E-1,.(Yij) = δ
√
(σ21,b2 + σ
2
-1,.)/2. Here, δ is a standardized
effect size (Cohen 1988) and σ2b1,b2 is the outcome’s unconditional variance under
DTR (b1, b2). For the prototypical SMART, formulae are developed for testing
null hypotheses of the form H0 : E1,b2(Yij)− E-1,c2(Yij) = 0 for a fixed (b2, c2) ∈
(−1, 1)2 against alternate hypotheses of the form H1 : E1,b2(Yij)− E-1,c2(Yij) =
δ
√
(σ21,b2 + σ
2
-1,c2)/2. The formulae are based on using (3) to estimate β in marginal
models of the form (1) or (2) as follows: (i) with or without a pre-specified cluster-level
covariate Xi, (ii) known weights W , and (iii) an exchangeable working covariance
structure for V . In addition, formulae are based on a constant cluster size mi = m for
all i (extensions to the unequal cluster size case can be done as in Kerry and Bland
(2001) or by conservatively setting m equal to the minimum cluster size), large sample
approximations, and rely on the following working population assumptions:
1. Equal exchangeable covariance matrices across regimens: We assume the
true unconditional covariance matrices are equal for the two DTRs we are
testing (e.g. Cov1,b2(Yi) = Cov−1,c2(Yi) = σ2 ∗ Exch(ρ) in the prototypical
SMART)
2. Conditional covariance inequality: For a specific DTR, we assume non-
responders do not vary from the marginal mean significantly more than
responders. This assumption applies to different DTRs based on design, see
below. A concern about this assumption should be raised only if the scientist,
apriori, believed that, for a specific DTR, non-responders had significantly larger
variances than responders or if the response rate was expected to be much larger
than .5 (which is atypical for SMART designs). See Appendix A for details.
3. Correct marginal mean model: We assume that Ea1,a2(Yij | Xi) =
µ(Xi, a1, a2;β, η) for the pre-specified cluster-level Xi, where
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µ(Xi, a1, a2;β, η) is of the form (1) or (2). When Xi is not included in
(1) or (2), this assumption is met trivially.
Each formula is a function of the cluster size m, the effect size δ, the outcome’s
ICC, ρ, the probability of a cluster responding after receiving initial treatment 1, p1
(i.e. p1 = P(R = 1|A1 = 1)), the probability of a cluster responding after receiving
initial treatment -1, p-1, and the standard normal quantiles zα/2 and zβ , where α is the
size of our test and 1− β is the power. We first provide formulae for estimation without
covariates followed by the case when a cluster-level covariate Xi is used.
ADEPT Sample Size Formula
For ADEPT, working assumption 2 is: E1,b2 [(Yi − µ(1, b2))(Yi − µ(1, b2))T |R =
0]  E1,b2 [(Yi − µ(1, b2))(Yi − µ(1, b2))T ] = Cov1,b2(Yi). Also, for ADEPT,
working assumption 1 can be relaxed to σ21,b2 ≤ σ2−1,.. Under these assumptions we
obtain the sample size formula:
N =
4(zβ + zα/2)
2
mδ2
· (1 + (m− 1)ρ) · (1 + 1− p1
2
) (5)
Prototypical Sample Size Formula
For Prototypical SMART designs, working assumption 2 is: for both DTRs in our test,
i.e. (a1, a2) = (1, b2) and (−1, c2), Ea1,a2 [(Yi − µ(a1, a2))(Yi − µ(a1, a2))T |R =
0]  Ea1,a2 [(Yi − µ(a1, a2))(Yi − µ(a1, a2))T ] = Cova1,a2(Yi). Under these
assumptions we obtain the sample size formula:
N =
4(zβ + zα/2)
2
mδ2
· (1 + (m− 1)ρ) · (1 + (1− p1) + (1− p-1)
2
) (6)
Note this formula is identical to the formula in Ghosh et al. (2015).
The sample size formulae in Equations 5 and 6 are intuitive. The first two terms
in both formulae are identical; these terms comprise the formulae for the sample size
for the difference in means in a 2-arm randomized control trial (RCT) with cluster-
level randomization (Donner and Klar 2010). The second term, in particular, is the
expression for the variance inflation factor (VIF) arising from cluster-randomized trials.
If ρ = 0 (i.e. VIF = 1), there is no inflation due to cluster randomization because we have
no correlation within clusters. As ρ increases, each new observation within a cluster
provides less unique information causing the VIF to increase. This, in turn, leads to an
increase in sample size, N .
The third term, which is unique to SMARTs, is used to account for the fact that some
clusters are re-randomized depending on response at the end of stage 1; hence, this last
term is a function of the rate of response to first stage intervention. To understand
this third term, it is useful to consider two extremes in the context of the prototypical
SMART: If both response rates (p1, p-1) are 1, then there is no re-randomization and the
design is analogous to a 2-arm cluster-randomized RCT (here, the third term is equal
to 1). If, on the other hand, both response rates are 0, then all clusters are randomized
twice; here, the third term is equal to 2. Note how the the third term is different for
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ADEPT and the prototypical SMART due to the difference in randomization schemes.
Also, in the special case where response rates to initial treatments are equal (i.e.
p1 = p-1), we would end up with the clustered version of the sample size formula in
Oetting et al. (2011).
Sample Size Formula with a Cluster-level Covariate
When including a cluster-level covariate in (1) or (2), working assumption 2 is similar
for each corresponding design, except it involves the conditional (on Xi) marginal
mean, i.e. Ea1,a2 [(Yi − µ(Xi, a1, a2))(Yi − µ(Xi, a1, a2))T |R = 0]  Ea1,a2 [(Yi −
µ(Xi, a1, a2))(Yi − µ(Xi, a1, a2))T ]. Also, our formula depends on Cor(Y,X),
which is the is the scalar correlation between the outcome Yij and the cluster-level
covariate Xi under the DTRs in our test. Note that under assumptions 1 and 3, this
correlation is constant across these DTRs. We obtain the following sample size formula
for ADEPT:
N =
4(zβ + zα/2)
2
mδ2
· (1 + (m− 1)ρ∗) · (1 + 1− p1
2
) · [1− Cor2(Y,X)] (7)
For the prototypical SMART, the sample size formula is:
N =
4(zβ + zα/2)
2
mδ2
· (1 + (m− 1)ρ∗) · (1 + (1− p1) + (1− p-1)
2
) · [1− Cor2(Y,X)]
(8)
where ρ∗ = ρ−Cor
2(Y,X)
1−Cor2(Y,X)
The use a covariate leads to two changes in the sample size formulae. First,
as expected, depending on the strength of the correlation between X and Y (i.e.,
Cor2(Y,X)), the use of a covariate has the potential to reduce the minimum required
sample size; this is because the use of covariates may improve the efficiency of our
estimator of β. Second, there is a reduction in sample size due to the reduction in
correlation, ρ∗, which, by definition, is always less than ρ.
Using the Sample Size Formula for the ADEPT study
To exemplify how the formula can be utilized in practice, we calculate the sample size
needed to detect a difference between DTRs (1,-1) and (-1,.) in ADEPT. This difference
would help us understand if it is better to give REP+EF+IF to non-responding clinics
initially, or to delay REP+EF+IF until a clinic is non-responsive to REP+EF. In
ADEPT, we expect the ICC of patient’s MH-QOL to be ρ = .01 and the probability
of responding when initially receiving REP+EF to be p1 = .2. Using the true sample
size ofN = 60, a common cluster size ofm = 10, and performing an α = .05 level test
(zα/2 = 1.96), by rearranging our formula, we conclude that at 80% power (zβ = .84)
we can detect an effect size of δ = .282.
Simulations
Simulations were conducted to evaluate the developed formulae and understand
their robustness to violations of the working assumptions. Specifically, we evaluate
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formulae under four scenarios: (1) satisfying all working assumptions, (2) violating
working assumption 1, (3) violating working assumption 2, and (4) violating working
assumption 3. Here, we present results for ADEPT; results were similar for the
prototypical SMART.
Details concerning the data generative model can be found in Appendix B. Data
were generated to mimic the ADEPT study. We considered different data generative
scenarios with varied standardized effect sizes (δ = .2 (small), .5 (moderate)), cluster
sizes (m = 5, 10, 20), ICC (ρ or ρ∗ = .01 or .1), and, when there is a cluster-
level covariate, the correlation between X and Y (Cor2(Y,X) ∈ [.04, .4]). We also
considered different scenarios constituting violations of the working assumptions
(details below). For each scenario, sample size was selected based on the proposed
formulae with power (1− β) = .9, α = 0.05. 1000 data sets were generated for each
scenario.
Each data set was analyzed as in the Implementation and Standard Error Estimation
sub-sections, using the marginal mean model in Equation 1. For each scenario, we
compared the estimated power (over 1000 data sets) to nominal power of .9.
Table 3. Power analysis of Formula 5
ICC, ρ Effect Size, δ Cluster Size, m Sample Size, N Assumptions Violating Violating
are correct Assumption 1 Assumption 2
.01 .2 5 306 .894 .891 .886
20 88 .917 .890 .876*
.5 5 49 .909 .898 .880*
10 26 .906 .878* .893
.1 .2 5 412 .910 .901 .870*
20 213 .922* .902 .891
.5 5 66 .909 .888 .898
20 34 .915 .913 .889
*The proportion is significantly different from .9 at the 5% level.
Table 3 describes simulation results for the sample size formula in Equation 5. To
violate assumption 1, we made the response variance under DTR(1, b2) 1.5 times the
response variance under DTR (−1, .). We could have also violated this assumption by
deviating from an exchangeable covariance structure, however, in cluster-randomized
trials it is rare to use an other covariance structure (Eldridge et al. 2009). To
violate assumption 2, we made non-responders have significantly larger variance than
responders under DTR (1, b2).
As expected, when no assumptions are violated (column 5), our estimated power
is close to our pre-specified power, .9. When assumption 1 is violated (column 6)
or assumption 2 is violated (column 7), we see that our power does not reduce
dramatically. Hence, we conclude that our sample size formula is robust to violations
of working assumptions 1 and 2.
Since working assumption 3 will always be true when there are no covariates,
we run a second simulation to evaluate the robustness of the sample size formula
in Equation 7 (i.e. with a cluster-level covariate) to this assumption. Specifically,
to violate assumption 3, we deviate from the linear marginal mean in Equation 1
by generating data with Ea1,a2(Yij |Xi) = β0 + β1a1 + β2a2Ia1=1 + ηfk(Xi) where
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fk(Xi) = Xi for Xi ∈ [−k, k], fk(Xi) = k for Xi > k, and fk(Xi) = −k for Xi <
−k (i.e. the linear marginal mean is misspecified outside of [−k, k]). Here η is chosen
to maintain the same values of Cor(Y,X). Setting k = 2 indicates a small violation
(column 7) and setting k = 1 indicates a large violation (column 8). We still, however,
analyze the data using the marginal mean model in Equation 1. The results are in
Table 4.
Table 4. Power analysis of Formula 7
ICC, ρ∗ Effect Size, δ Cluster Size, m Cor2(Y,X) Sample Size, N Assumptions Small Large
are correct Violation of Violation of
Assumption 3 Assumption 3
.01 .2 5 .238 233 .909 .904 .859*
20 .238 65 .903 .879* .777*
.5 5 .043 47 .891 .901 .902
10 .066 24 .893 .903 .897
.1 .2 5 .243 305 .918 .900 .890
20 .243 159 .915 .922* .864*
.5 5 .043 63 .898 .916 .919*
20 .043 32 .908 .920* .899
*The proportion is significantly different from .9 at the 5% level.
As expected, when no assumptions are violated (column 6), our estimated power is
close to our pre-specified power, .9. Note the reduction in sample size caused by the
addition of a covariate. Under a small violation (column 7), we see the power is not
significantly reduced. Under a large violation (column 8), we see our power is lowest
when X and Y are moderately correlated and the sample size is low. This is because
when X and Y are weakly correlated, the overall influence of X is small, and hence
misspecification of the relationship between X and Y will have little influence on our
estimation and power.
Discussion and Future Work
This manuscript presents a regression estimator and sample size formulae for
comparing embedded dynamic treatment regimens using data arising from a cluster-
randomized SMART. Methods were motivated by the ADEPT SMART, a study
designed to develop a dynamic treatment regimen (at the level of community based
mental health clinics) designed to improve mental health outcomes for patients
clustered within those sites (Kilbourne et al. 2014). Sample size formulae were derived
for both ADEPT and for a more common type of SMART.
There are a number of directions for future research in the analysis of cluster-
randomized SMARTs. First, relatively staightforward applications of the estimator in
Equation 3 with different link functions can be used to analyze, for example, binary,
count or zero-inflated outcomes.
Second, in practice, many cluster-randomized SMARTs will collect longitudinal
(i.e., repeated measures) research outcomes at the patient-level. A natural next step is
to combine the estimator presented here with methods for the analysis of longitudinal
SMART outcomes (Lu et al. 2015) in order to accomodate two levels of clustering:
repeated measures within patients within clusters.
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Third, future work could also consider the use of variance components models, i.e.,
mixed effects or random effects models (Hedeker and Gibbons 2006; Raudenbush and
Bryk 2002), which are now-standard in the analysis of randomized trials.
Fourth, while this manuscript focuses on the analysis of primary aims in a SMART,
in the DTR literature there is much interest in the development and application of
analysis methods designed to generate hypotheses about more individually-tailored
DTRs (Zhao et al. 2015; Laber et al. 2014; Zhang et al. 2015; Laber and Zhao 2015;
Linn et al. 2014; Qian and Murphy 2011; Moodie et al. 2014; Zhou et al. 2015). Much
of this literature has focused on identifying optimal DTRs at the individual level. Such
methods could be extended for the analysis of data arising from cluster-randomized
SMARTs to develop optimal cluster-level DTRs.
There are also a number of interesting methodological issues related to the design
of cluster-randomized SMARTs (with implications for analysis methods). First, the
sample size formulae derived here were limited to cases where our data contains a
single cluster-level covariate. Future work may provide extensions to data containing
multiple covariates and individual-level covariates.
Second, in this manuscript we focus on SMARTs that are useful for developing of
cluster-level DTRs where the initial and subsequent decisions are all at the cluster-level.
However, there is currently much interest by educational scientists in SMARTs aimed
at developing DTRs where sequences of intervention decisions are made at both the
cluster and individual level. For example, we are currently involved in the conduct of
a trial where the first stage intervention is at the level of classrooms with children with
autism (such classrooms often include 1 to 3 children with autism), and the subsequent
stages of intervention are at the level of the children themselves (Kasari et al. 2016).
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Appendix A: Derivation of Sample Size Formulae
Here we derive the sample size formula. We begin with deriving the sample size
formula for a prototypical design with no covariates. Then we make simple extensions
to formula under an ADEPT design and/or when a cluster-level covariate is included.
All sample size formulae are based primary aim (iv), that is the marginal mean
comparison of two dynamic treatment regimens that begin with a different initial
treatment (i.e., E1,b2(Yij)− E-1,c2(Yij)).
Also, for simplicity, these derivations assume the marginal mean model is
parameterized as follows:
For Prototypical:
µ(Xij , a1, a2;β, η) = β0I{a1 = 1, a2 = 1}+ β1I{a1 = 1, a2 = −1}+
β2I{a1 = −1, a2 = 1}+ β3I{a1 = −1, a2 = −1}+ ηTXij
For ADEPT:
µ(Xij , a1, a2) = β0I{a1 = 1, a2 = 1}+ β1I{a1 = 1, a2 = −1}+
β2I{a1 = −1}+ ηTXij
Fitting the re-parameterized models will yield the exact same conclusions as fitting
the marginal mean models in Equations 1 and 2.
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Prototypical Design without Covariates
For data arising from a prototypical SMART design, we derive the sample size formula
for detecting a significant difference between mean outcomes from two treatment
regimens, (b1, b2) and (c1, c2). Since we are interested in comparing two regimes
starting with different initial treatment. Hence, without loss of generality, assume
b1 = 1 and c1 = -1.
We are interested in the following hypothesis test:
H0 : E1,b2(Yij)− E-1,c2(Yij) = 0
against the alternative
H1 : E1,b2(Yij)− E-1,c2(Yij) = δσ
where σ =
√
σ21,b2
+σ2-1,c2
2 , σ
2
a1,a2 = Vara1,a2(Yij), and δ is the standardized effect size.
We make a series of assumptions to derive our sample size formulae. We highlight
these assumptions throughout our derivation to illustrate there use in the calculation.
Note that our sample size is developed for a fixed cluster size, m (extensions to the
unequal cluster size case can be done as in Kerry and Bland (2001)).
Our test statistic used for the hypothesis test is
Z =
√
N(µˆ(1, b2)− µˆ(-1, c2))√
τˆ2(1, b2) + τˆ2(-1, c2)− 2Ĉov(
√
Nµˆ(1, b2),
√
Nµˆ(-1, c2))
Here, τˆ2(a1, a2) is an approximation of the variance, τ2(a1, a2) =
Var(
√
Nµˆ(a1, a2)) as given in the supplementary material.
In large samples and under assumption 3 described in the Sample Size
Formulae section, the distributions of µˆ(1, b2) and µˆ(-1, c2) can be approximated
by the normal distribution, τˆ2(1, b2) ≈ τ2(1, b2), τˆ2(-1, c2) ≈ τ2(-1, c2), and
Ĉov(
√
Nµˆ(1, b2),
√
Nµˆ(-1, c2)) ≈ Cov(
√
Nµˆ(1, b2),
√
Nµˆ(-1, c2)) = 0 (here the
covariance is 0 due to the independence of estimators of marginal means with different
initial treatments). Thus, Z approximately has a standard normal distribution under the
null hypothesis.
Note that these calculations are exactly the same as those highlighted in the
Hypothesis Testing section. Specifically, under the original parameterization, letting
c = (0, 2, b2 − c2, b2 + c2, 0p)T then cT (βˆ, ηˆ) = µˆ(1, b2)− µˆ(-1, c2) and cΣˆβˆ,ηˆ cT =
τˆ2(1, b2) + τˆ
2(-1, c2)− 2Ĉov(
√
Nµˆ(1, b2),
√
Nµˆ(-1, c2)).
Under the alternative, our test statistic is normal with approximate mean√
Nδσ/
√
τ2(1, b2) + τ2(-1, c2) and variance 1. Doing standard power calculations
(Oetting et al. 2011) for a hypothesis test of size α, in order to obtain desired power of
1− β, we need to find N that satisfies:
zβ ≈ −zα/2 + δσ
√
N√
τ2(1, b2) + τ2(-1, c2)
N =
(zβ + zα/2)
2(τ2(1, b2) + τ
2(-1, c2))
δ2σ2
(9)
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Everything in this formula can be explicitly found except τ2(1, b2) and τ2(-1, c2).
Hence we now aim to derive upper bounds for these variables in order to write our
sample size formula in terms of either known or easily elicited quantities.
Note that under the parameterization, for any DTR (a1, a2), τ2(a1, a2) =
Var[
√
Nµˆ(a1, a2)] = [Σβˆ ](a1,a2) = [J
-1E[UiU
T
i ]J
-1](a1,a2) , with Ui and J defined
in the supplementary material. Here, for ease, for the 4x4 matrices, M = Σβˆ , J, or
E[UiUTi ], we define [M ](a1,a2) as the diagonal element corresponding to DTR (a1, a2)
(e.g. the (3,3) element for DTR (−1, 1)). Also, 1m is defined as the mx1 vector of
1’s. Lastly, as defined in the Sample Size Formulae section, pa1 is the probability of
responding given the cluster had received initial treatment a1.
After simplification, we find J is a diagonal matrix with diagonal element:
[J ](a1,a2) = E[WiIi(a1,a2)1
T
mV
-1(a1, a2)1m] = 1
T
mV
-1(a1, a2)1m
For E[UiUTi ](a1,a2), we perform the following simplification:
E[UiU
T
i ](a1,a2) =
E[W 2i Ii(a1,a2)1
T
mV
-1(a1, a2)(Yi − µ(a1, a2))(Yi − µ(a1, a2))TV -1(a1, a2)1m] =
1TmV
-1(a1, a2)Ea1,a2 [Wi(Yi − µ(a1, a2))(Yi − µ(a1, a2))T ]V -1(a1, a2)1m =
1TmV
-1(a1, a2)[2Ea1,a2 [(Yi − µ(a1, a2))(Yi − µ(a1, a2))T |R = 1]pa1 +
4Ea1,a2 [(Yi − µ(a1, a2))(Yi − µ(a1, a2))T |R = 0](1− pa1)]V -1(a1, a2)1m =
2 ∗ 1TmV -1(a1, a2)Σa1,a2V -1(a1, a2)1m +
2(1− pa1) ∗ 1TmV -1(a1, a2)Ea1,a2 [(Yi − µ(a1, a2))(Yi − µ(a1, a2))T |R = 0]
·V -1(a1, a2)1m
To go from line 2 to 3, we assume Robin’s consistency assumption holds, i.e. that the
cluster’s observed outcomes equal the cluster’s potential outcomes under the observed
DTR (Robins 1997). Under this assumption we are able to switch from E, which is an
expected value over observed data, to Ea1,a2 which is the expected value had the entire
population received DTR (a1, a2) (Rubin 1978; Neyman et al. 1935).
For further simplification, we now make assumption 2. This assumption is equivalent
to assuming, for a specific DTR (a1, a2) (we drop the a1, a2 from the subscripts
for convenience): |(σ2RρR − σ2NRρNR)pa1 + (µR − µNR)2(pa1)(1− 2pa1)| ≤
(σ2R − σ2NR)pa1 + (µR − µNR)2(pa1)(1− 2pa1), where µR, σ2R, ρR are the
mean, variance, and ICC of responders had the whole population received
DTR (a1, a2), (i.e. µR = Ea1,a2(Yij |Ri = 1), σ2R = Vara1,a2(Yij |Ri = 1), ρR =
Cova1,a2(Yi1, Yi2|Ri = 1)/Vara1,a2(Yij |Ri = 1)), similarly defined for NR and
non-responders (i.e. conditional on R = 0). Also, pa1 is the probability of response,
given initial treatment a1.
For DTR (a1, a2), this condition is satisfied if the probability of response is less than
or equal to .5 (which is typical for prototypical SMART designs), the non-responders of
that regimen have a variance which is less than or equal to the variance of responders
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of the regimen, and both responders and non-responders have similar within cluster
covariances.
Under assumption 2 we can bound and simplify our expression for E[UiUTi ](a1,a2)
as
E[UiU
T
i ](a1,a2) 
2(1 + (1− pa1)) ∗ 1TmV -1(a1, a2)Σa1,a2V -1(a1, a2)1m
We next utilize the fact that our working covariance matrix, V, is exchangeable. With
some linear algebra, this assumption allows us to perform the following simplification:
2(2−pa1 )1TmV -1(a1,a2)Σa1,a2V -1(a1,a2)1m
(1TmV
-1(a1,a2)1m)2
=
2(2−pa1 )1TmΣa1,a21m
m2
Next, using assumption 1, we exploit the exchangeable population covariance struc-
ture (i.e. Cova1,a2(Yi) = σ2a1,a2 ∗ Exch(ρa1,a2 ), where ρa1,a2 = Cora1,a2(Yi1, Yi2)).
Putting everything together, we obtain:
τ2(a1, a2) = Var[
√
Nµˆ(a1, a2)]
3
= [J -1E[UiU
T
i ]J
-1](a1,a2)
2≤
2(2− pa1)1TmV -1(a1, a2)Σa1,a2V -1(a1, a2)1m
(1TmV
-1(a1, a2)1m)2
=
2(2− pa1)1TmΣa1,a21m
m2
1
=
2(2− pa1)σ2a1,a2 [1 + (m− 1)ρa1,a2 ]
m
(10)
We utilize the across regimen covariance equality of assumption 1 in order to
simplify things further. Note that if one had good estimates of σ2a1,a2 and ρa1,a2 , then
you could easily obtain N by plugging in the values into equation 10 and then using
these estimates in equation 9.
Using this equality, we combine equation 10 with equation 9 and simplify to obtain:
N =
4(zβ + zα/2)
2
mδ2
· (1 + (m− 1)ρ) · (1 + (1− p1) + (1− p-1)
2
)
ADEPT Design without Covariates
All the calculations done above are nearly identical for the ADEPT case. The only
major difference arises from the lack of re-randomization of clusters receiving initial
treatment a1 = −1. This in fact makes the calculations simpler for τ2(−1, .) In
particular, we assume assumptions 1 and 3, however, assumption 2 only needs to be
assumed for DTR (1,b2). Under these assumptions we obtain:
τ2(1, b2) ≤
2(2− p1)σ21,b2 [1 + (m− 1)ρ1,b2 ]
m
, τ2(-1, .) =
2σ2-1,.[1 + (m− 1)ρ-1,.]
m
(11)
After utilizing the across regimen population covariance equality of assumption 1,
we combine the equation 11 with equation 9 and simplify to obtain:
N =
4(zβ + zα/2)
2
mδ2
· (1 + (m− 1)ρ) · (1 + 1− p1
2
)
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For this sample size formula, we actually only need to assume σ21,b2 ≤ σ2−1,. (as
opposed to the equality assumed in assumption 1) to ensure our power is larger than 1
- β.
With a Cluster-Level Covariate
In this section, we write the sample size formula when adding a single cluster-
level covariate to the model (i.e. the mx1 vector Xi , (Xi1, Xi2, . . . , Xim)T =
(Xi, Xi, . . . , Xi)
T ). First, for DTR (a1, a2), we define σ2∗a1,a2 ,
Ea1,a2 [Vara1,a2(Yij |Xi)], and ρ∗a1,a2 , Ea1,a2 [Cova1,a2(Yi1, Yi2|Xi)]/σ2∗a1,a2 , where
the expectations are taken over Xi. Note in the homoscedastic case, the expectation is
unnecessary since the conditional variances and covariances are constant for all Xi.
The key to extending our formulae to the covariate case is observing that
the numerator of our sample size formula will now be in terms of the average
conditional variances and ICCs, σ2∗a1,a2 and ρ
∗
a1,a2 , while the denominator remains
in terms of the overall variance, σ2a1,a2 . Since σ
2
a1,a2 = σ
2∗
a1,a2 + η
2V ar(Xi) and
Cova1,a2(Yi1, Yi2) = Ea1,a2 [Cova1,a2(Yi1, Yi2|Xi)] + η2V ar(Xi), then σ2∗a1,a2 and
ρ∗a1,a2 must be less than or equal to σ
2
a1,a2 and ρa1,a2 . Thus the numerator of our
formula is reduced while the denominator remains the same. With some algebra, this
reduction is shown to be 1− Cor2(Yij , Xi). Note that this reduction can be shown to be
the same reduction arising from including a cluster-level covariate in clustered RCTs,
see Hedges and Rhoads (2009).
For simplification, we do all calculations assuming our covariate has mean 0 (this
eliminates covariance between our marginal mean estimates). When our covariate does
not have mean 0, one can show that mean centering our covariate does not change the
value of our test statistic, and hence does not change our power. Thus our sample size
formula remains valid when the covariate does not have mean 0.
Prototypical Design Using assumptions 1-3, the relationships above, and doing similar
algebra as in the non-covariate case (except now everything is in terms of σ2∗a1,a2 and
ρ∗a1,a2 ), we obtain for both DTRs of interest:
τ2(a1, a2) ≤
2(2− p1)σ2∗a1,a2 [1 + (m− 1)ρ∗a1,a2 ]
m
(12)
Making assumption 1 (on unconditional population variances and correlations) will
lead to equality of expected conditional variances and correlations due to the simple
relationship between the conditional and unconditional variances and covariances
highlighted above. Hence we define ρ∗ , ρ∗1,b2 = ρ
∗
−1,c2 and σ
2∗ , σ2∗1,b2 = σ
2∗
-1,c2 .
We also take advantage of the fact that Cor21,b2(Yij , Xi) = η
2Var(Xi)/σ21,b2 =
η2Var(Xi)/σ2−1,c2 , i.e. is also equal across both regimes. We define Cor
2(Y,X) ,
Cor21,b2(Yij , Xi) = Cor
2
−1,c2(Yij , Xi).
Ultimately, we obtain :
N =
4(zβ + zα/2)
2
mδ2
(1 + (m− 1)ρ∗)(1 + (1− p1) + (1− p-1)
2
)[1− Cor2(Y,X)]
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ADEPT Design Similar to the prototypical design, under assumptions 1-3, for DTR
(1, b2) we obtain the same bound as in equation 12. For DTR (-1, .), without utilizing
assumption 2, we obtain:
τ2(−1, .) = 2σ
2∗
−1,.[1 + (m− 1)ρ∗−1,.]
m
And, utilizing equality of population covariance across regimens:
N =
4(zβ + zα/2)
2
mδ2
(1 + (m− 1)ρ∗)(1 + 1− p1
2
)[1− Cor2(Y,X)]
Also, with some algebra, ρ∗ can be expressed as ρ∗ = (ρ− Cor2(Y,X))/(1−
Cor2(Y,X)), allowing our two covariate sample size formulae to be a function purely
of ρ and Cor2(Y,X).
Appendix B: Data-generative Models Used in Simulation
Experiments
Below we describe how we generated data for our simulations.
Without Covariates
For Table 3, we generate data, (A1, R,A2, Y ), for each of the N clusters as follows:
1. Generate A1 to be 1 or -1 with equal probability
2. Generate R to be 1 with probability pA1 and 0 otherwise
3. GenerateA2 to be 1 or -1 with equal probability, for clusters withA1 = 1,R = 0
4. Generate the mx1 vector Y = µA1,R,A2 + , where  ∼
MVN(0,ΣA1,R,A2), where ΣA1,R,A2 = σ
2
A1,R,A2
· Exchm(ρA1,R,A2). Here
µA1,R,A2 , σ
2
A1,R,A2
, ρA1,R,A2 are the cell means, variances, and ICCs since
they correspond to each cell in Figure 1.
Table 5. Pre-specified simulation values for Table 3
Simulation p1 p-1 µ1,1,. µ1,0,1 µ1,0,−1 µ−1,1,. µ−1,0,. σ21,1,.
Table 3, Row 1, Col 5 .2 .3 34.71 32.71 28 32.7 31 63.36
Table 3, Row 1, Col 6 .2 .3 34.71 32.71 28 32.14 31.44 63.36
Table 3, Row 1, Col 7 .2 .3 33.36 33.05 28 32.7 31 1
Simulation σ21,0,1 σ
2
1,0,−1 σ
2
−1,1,. σ
2
−1,0,. ρ1,1,. ρ1,0,1 ρ1,0,−1 ρ−1,1,. ρ−1,0,.
Table 3, Row 1, Col 5 63.36 60 63.39 63.39 0.0 0.0 0.0 .0006 .0006
Table 3, Row 1, Col 6 63.36 60 43 43 0.0 0.0 0.0 .0076 .0076
Table 3, Row 1, Col 7 79.73 60 63.39 63.39 0.9 .007 0.0 .0006 .0006
Under these specified means, variances, and ICCs, one can easily obtain the desired
marginal (over R) means, variances, and ICCs under a specific DTR using the
laws of total expectation and variation. For example, to obtain the marginal mean
under DTR (1,1), one would calculate µ1,1,.p1 + µ1,0,1(1− p1). To calculate the
variance under DTR (1,1), one would calculate σ21,1,.p1 + σ
2
1,0,1(1− p1) + p1(1−
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p1)(µ1,1,. − µ1,0,1)2. To calculate the covariance under DTR (1,1), one would calculate
σ21,1,.ρ1,1,.p1 + σ
2
1,0,1ρ1,0,1(1− p1) + p1(1− p1)(µ1,1,. − µ1,0,1)2
When no assumptions were violated (row 1 of Table 5), the cell means and variances
were first chosen to give marginal means and variances which are both similar to results
expected in ADEPT and produce effect sizes matching Table 3. After obtaining the
correct effect size, the cell ICCs were then chosen also to match values specified in
Table 3. To violate assumptions (row 2 and 3 of Table 5), the cell means, variances, and
ICCs from row 1 were slightly altered to create the correct violations.
With a Cluster-Level Covariate
To generate data for Table 4, we use a continuous cluster-level covariate. We generate
data, (X,A1, R,A2, Y ), for each of the N clusters as follows:
1. Generate A1 to be 1 or -1 with equal probability
2. Generate R to be 1 with probability pA1 and 0 otherwise
3. GenerateA2 to be 1 or -1 with equal probability, for clusters withA1 = 1,R = 0
4. Generate a single cluster-level covariate X from Normal(0,1)
5. a. Generate mx1 vector Y = µA1,R,A2 + ηX +  for Column 6
b. Generate mx1 vector Y = µA1,R,A2 + ηfk(X) +  for Columns 7, 8
where  ∼MVN(0,ΣA1,R,A2), with ΣA1,R,A2 = σ2∗A1,R,A2 · Exchm(ρ∗A1,R,A2).
Here µA1,R,A2 , σ
2∗
A1,R,A2
, ρ∗A1,R,A2 are the cell means, conditional cell
variances, and conditional cell ICCs since they correspond to each cell in Figure
1. Also, fk is the same piecewise function defined in the Simulations section (i.e.
which is non-linear outside of [−k, k]).
Table 6. Pre-specified simulation values for Table 4
Simulation k p1 p-1 η µ1,1,. µ1,0,1 µ1,0,−1 µ−1,1,. µ−1,0,. σ2∗1,1,.
Table 4, Row 1, Col 6 .2 .3 4.47 34.94 32.94 28 32.7 31 63.36
Table 4, Row 1, Col 7 2 .2 .3 4.69 34.95 32.95 28 32.7 31 63.36
Table 4, Row 1, Col 8 1 .2 .3 6.66 34.98 32.98 28 32.7 31 63.36
Simulation σ2∗1,0,1 σ
2∗
1,0,−1 σ
2∗
−1,1,. σ
2∗
−1,0,. ρ
∗
1,1,. ρ
∗
1,0,1 ρ
∗
1,0,−1 ρ
∗
−1,1,. ρ
∗
−1,0,.
Table 4, Row 1, Col 6 63.36 60 63.39 63.39 0.0 0.0 0.0 .0006 .0006
Table 4, Row 1, Col 7 63.36 60 63.39 63.39 0.0 0.0 0.0 .0006 .0006
Table 4, Row 1, Col 8 63.36 60 63.39 63.39 0.0 0.0 0.0 .0006 .0006
Under these specified conditional means, variances, and ICCs, one can again obtain
the desired conditional and unconditional marginal means, variances, and ICCs under
a specific DTR using the laws of total expectation and variation. For example,
to obtain the conditional marginal variance under DTR (1,1), one would calculate
σ2∗1,1 = σ
2∗
1,1,.p1 + σ
2∗
1,0,1(1− p1) + p1(1− p1)(µ1,1,. − µ1,0,1)2. For data generated as
in 5a, to obtain the unconditional marginal variance under DTR (1,1), one would
calculate σ21,1 = σ
2∗
1,1 + η
2Var(X). For data generated as in 5b, we instead calculate
σ21,1 = σ
2∗
1,1 + η
2Var(fk(X)). Both Var(X) and Var(fk(X)) can be found using the
known distribution of X .
The cell means, conditional variances, and conditional ICCs were chosen for the
same reason as in the non-covariate case. η was chosen to give the correct correlation
between X and Y .
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Supplementary Materials
Asymptotic results for the estimator
This section shows consistency and asymptotic normality of the proposed estimator.
These proofs are similar to those found in Lu et al. (2016). In Equation 3 the estimator
was presented with fixed working covariance matrices, V (a1, a2,mi), and known
weights, Wi. However, in practice V (a1, a2,mi) must be estimated and the known
weights can be estimated to improve efficiency, see Robins et al. (1995); Hernan et al.
(2002); Hirano et al. (2003); Brumback (2009); Williamson et al. (2014); Bembom and
van der Laan (2007). Additionally, we may want the covariance matrices to be functions
of baseline covariates. We also may want to allow weights to depend on baseline
covariates, Xi, information collected prior to first randomization, L0i, and information
collected between the first and second randomization, L1i. Specifically, we allow
Wi = 1/(Pr(A1i|Xi,L0i)Pr(A2i|Xi,L0i, A1i,L1i, Ri)). We represent V (a1, a2,mi)
and Wi by V (Xi, a1, a2,mi; αˆ) and Wi(γˆ), where αˆ and γˆ arise from estimation of V
and W . We also allow for cluster sizes to be unequal across observations since this is
typical in practice. Under these general settings, the estimating equation is:
0 =
1
N
N∑
i=1
∑
(a1,a2)
I(A1i, Ri, A2i, a1, a2)Wi(γˆ)
·D(Xi, a1, a2)TV (Xi, a1, a2,mi; αˆ)-1(Yi − µ(Xi, a1, a2;β, η)),
(13)
We first demonstrate the consistency of the estimator found by solving this equation.
Theorem 1. Assume the marginal model is correctly specified, that is,
Ea1,a2 [Yij |Xij ] = µ(Xij , a1, a2;β0, η0), where (β0, η0) is the true value for
the parameter (β, η) in the marginal mean model. Assume Yij is conditionally
independent of Xik ∀k 6= j given Xij . Also assume that there exists α+, γ0 such that√
N(αˆ− α+) = Op(1) and
√
N(γˆ − γ0) = Op(1) (i.e. are bounded in probability),
where Wi(γ0) ≡Wi, the true inverse-probability weight. Then the estimator (βˆ, ηˆ)
obtained by solving Equation 13 is consistent for (β0, η0).
Proof. Define θ = (β, η) to denote the marginal mean model parameters with
true values θ0 = (β0, η0). We denote the estimating equation in 13 as 0 =
1/N
∑N
i=1 Ui(Zi; θ, αˆ, γˆ), where Zi is all observed covariates and responses
for cluster i. It remains to show that E[Ui(Zi; θ0, α+, γ0)] = 0p+q , from which
consistency can be established as done for the standard GEE estimator (Liang and
Zeger 1986). Here the expectation is over observed data (with respect to the distribution
of the observed data, Pobs) as opposed to Ea1,a2 , which is an expectation over data
arising as if all clusters had received DTR (a1, a2) (with respect to the distribution
Pa1,a2 ).
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Note that I(A1i, Ri, A2i, a1, a2)/Wi is the Radon-Nikodym derivative betweenPobs
and Pa1,a2 . And thus,
E[Ui(Zi; θ0, α
+, γ0)] =∑
(a1,a2)
Ea1,a2 [D(Xi, a1, a2)
TV (Xi, a1, a2,m;α+)-1(Yi − µ(Xi, a1, a2; θ0))]
∑
(a1,a2)
EXi [D(Xi, a1, a2)
TV (Xi, a1, a2,m;α+)-1]Ea1,a2 [Yi − µ(Xi, a1, a2; θ0)|Xi]
= 0p+q
The final equation equals zero due to the conditional independence and correct
specification of the marginal mean model.
We next prove the asymptotic normality of our estimator obtained in equation 13.
We borrow notation from the previous proof.
Theorem 2. Assuming mild regularity conditions, the same assumptions as in
Theorem 1, the cluster sizes are bounded, and that the weight parameter γ is obtained
from maximum likelihood estimation for treatment assignment probabilities, with a
score function Sγ . Then
√
N((βˆ, ηˆ)− (β0, η0)) is asymptotically multivariate normal
with zero mean and covariance matrix Σβˆ,ηˆ = J
-1(A− CB-1CT )J -1, where A, B, C,
and J are given by
J = lim
N→∞
1
N
N∑
i=1
E
∑
(a1,a2)
I(A1i, Ri, A2i, a1, a2)Wi(γ0)
·D(Xi, a1, a2)TV (Xi, a1, a2,mi;α+)-1D(Xi, a1, a2)
A = lim
N→∞
1
N
N∑
i=1
E[UiU
T
i ], B = lim
N→∞
1
N
N∑
i=1
E[Sγ0,iS
T
γ0,i], C = limN→∞
1
N
N∑
i=1
E[UiS
T
γ0,i]
with Ui , Ui(Zi; θ0, α+, γ0)
Proof: Using the same argument for GEE estimators (Liang and Zeger 1986) we
obtain
√
N(θˆ − θ0) =
[
lim
N→∞
1
N
N∑
i=1
∂Ui(Zi; θ0, α
+, γ0)
∂θ
]-1{
1√
N
N∑
i=1
Ui(Zi; θ0, α
+, γ0)
+
[
lim
N→∞
1
N
N∑
i=1
∂Ui(Zi; θ0, α
+, γ0)
∂γ
]√
N(γˆ − γ0)
}
+ op(1)
Using the fact that Sγ is the score function for γˆ to express
√
N(γˆ − γ0) as a sum.
Also, using the fact that our cluster size is bounded combined with the Law of Large
Numbers, we write all long-run averages of random variables as long run averages of
expectations. Hence, we obtain:
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√
N(θˆ − θ0) =
[
lim
N→∞
1
N
N∑
i=1
E
{
∂Ui
∂θ
}]-1{
1√
N
N∑
i=1
Ui−
 lim
N→∞
1
N
N∑
j=1
E(UjS
T
γ0,j)
 lim
N→∞
1
N
N∑
j=1
E(Sγ0,jS
T
γ0,j)
-1 Sγ0,i
+ op(1)
= J -1
1√
N
N∑
i=1
(Ui − CB-1Sγ0,i) + op(1)→ Normal[0, J -1(A− CB-1CT )J -1]
Remark: Note that with unequal cluster sizes, Ui and Sγ,i are not identically
distributed, and hence we must express our variances with long run averages. If
cluster sizes were equal, averaging would not be necessary and we would obtain
A = E[UiU
T
i ], B = E[Sγ0S
T
γ0 ], C = E[UiS
T
γ0 ], and J = E[∂Ui/∂θ].
To obtain estimates for our standard error of (βˆ, ηˆ) we use plug in estimates of A, B,
C, and J. Specifically, we set:
Jˆ =
1
N
N∑
i=1
∑
(a1,a2)
I(A1i, Ri, A2i, a1, a2)Wi(γˆ)
·D(Xi, a1, a2)TV (Xi, a1, a2,mi; αˆ)-1D(Xi, a1, a2)
Aˆ =
1
N
N∑
i=1
UˆiUˆ
T
i , Bˆ =
1
N
N∑
i=1
Sγˆ,iS
T
γˆ,i, Cˆ =
1
N
N∑
i=1
UˆiS
T
γˆ,i
where Uˆi = Ui(Zi; θˆ, αˆ, γˆ)
Thus, the plug in estimator for Σθˆ is Σˆθˆ = Jˆ
-1(Aˆ− CˆBˆ-1CˆT )Jˆ -1 and we obtain
V̂ ar(θˆ) = 1/N · Σˆθˆ.
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